StockNews.com upgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Several other equities analysts also recently commented on the stock. DNB Markets downgraded shares of Novo Nordisk A/S from a buy rating to a hold rating in a […]
C WorldWide Thematic Specialist Morten Springborg says his firm has outperformed by taking a much longer-term approach than is usual for money managers.